Clinical trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 7 |
| Terminated | 4 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 3 |
| Bristol-Myers Squibb | 2 |
| Instituto do Cancer do Estado de São Paulo | 2 |
| Columbia University | 1 |
| Gamida Cell ltd | 1 |
| Hospital Israelita Albert Einstein | 1 |
| Instituto Nacional de Cancer, Brazil | 1 |
| Leonardo Javier Arcuri | 1 |
| Nelson Hamerschlak | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 20 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Myelodysplastic Syndromes | 3 |
| Graft vs Host Disease | 2 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Neoplasm, Residual | 2 |
| Recurrence | 2 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.